Search
BERKELEY LAB CELEBRATES THE INTEGRATIVE GENOMICS BUILDING
Biosciences Area Associate Lab Director Mary Maxon caps off the Integrative Genomics Building dedication festivities by leading the...
INDIGO BIOSCIENCES ANNOUNCES RELEASE OF ASSAY KIT FOR TESTING MULTI-DRUG RESISTANCE
Testing Allows Researchers to Determine Possibility of Drug-Drug Interactions Before Clinical Trials State College, PA - INDIGO Biosciences,...
HERE COMES THE SUN: A NEW FRAMEWORK FOR ARTIFICIAL PHOTOSYNTHESIS
Scientists have long sought to mimic the process by which plants make their own fuel using sunlight, carbon dioxide, and water through...
BIO ROUNDUP: ROCHE-SPARK DRAGS ON, GSK TAPS CRISPR, DIABETES NEWS & MORE
Is one of the bigger biopharma acquisitions of the year in trouble? This past week, antitrust regulators once again delayed Roche's...
THE SMRT SPECIAL: JOURNAL FOCUSES ON ADVANCES IN SMRT SEQUENCING
Single Molecule, Real-Time Sequencing continues to get smarter and more powerful, with the recent launch of the Sequel II system increasing...
WITH YALE TECH AND $12M, ARTIZAN AIMS FOR ROOT CAUSE OF GUT DISEASE
A number of startups are targeting the gut microbiome as a way to potentially treat disease, but identifying specific microbes at the...
AGTECH STARTUP GROGURU GETS AUDIENCE KUDOS AT EVONEXUS DEMO DAY
Three wildly different startups among those incubating at EvoNexus, a La Jolla, CA-based nonprofit organization that supports early-stage...
BERKELEY LAB TECHNOLOGY PROVIDES CLARITY AMID HAWAIIAN WATER CONTAMINATION CONCERNS
At Gillin's Beach in the Mahaulepu watershed, signs were frequently posted warning beach goers not to swim. However, the team found...
THE FUTURE IS BRIGHT FOR SOMATIC CELL GENOME EDITING
Scientific advances in human genome editing have proven that somatic cell genome editing holds great potential to treat or maybe even...
UNRAVELING MALARIA MYSTERIES WITH LONG-READ SEQUENCING
Plasmodium falciparum Malaria is a complicated killer, and efforts to develop effective vaccines have been hindered by gaps in our...
WITH $35M, WHOLE BIOME EYES 2020 LAUNCH OF MEDICAL FOOD FOR DIABETES
Diabetes treatments available today include shots and pills intended to restore the hormone balance that leads to healthy blood sugar...
BREAKTHROUGH TECHNIQUE FOR STUDYING GENE EXPRESSION TAKES ROOT IN PLANTS
Researcher Christine Shulse tends to Arabidopsis plants in a lab at the DOE Joint Genome Institute. An open-source RNA analysis platform...
BIO 2019 INNOVATION ZONE COMPANY SNAPSHOT: TRELLIS BIOSCIENCES
The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, or one conversation for a small, emerging...
SOLID TANKS AS SAFETY SCARE AGAIN ROCKS DMD GENE THERAPY
A safety scare has rocked Solid Biosciences' drive to get its Duchenne muscular dystrophy gene therapy program back on track. The first...
PROMETHERA RAISES €40M TO FUND TRIAL OF NASH CELL THERAPY
Promethera Biosciences has raised €39.7 million to put its liver disease cell therapy through clinical trials. The series D round comes...
NEUROCRINE BIOSCIENCES HONORS MENTAL HEALTH MONTH AND RAISES AWARENESS OF TARDIVE DYSKINESIA AND ITS IMPACT ON PATIENTS
Mental Health Advocacy Community Recognizes and 25 States Declare Tardive Dyskinesia Awareness Week as Part of Mental Health Month...
FOUR BERKELEY LAB SCIENTISTS ELECTED AS NATIONAL ACADEMY OF SCIENCES MEMBERS
New NAS members Roger Falcone, Pamela Ronald, Uros Seljack, and Omar Yaghi. Four Lawrence Berkeley National Laboratory scientists...
UNIQUE SYNTHETIC ANTIBODIES SHOW PROMISE FOR IMPROVED DISEASE AND TOXIN DETECTION
Scientists have invented a new “synthetic antibody” that could make screening for diseases easier and less expensive than current go-to...
NEUROCRINE BIOSCIENCES REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS
INGREZZA® First Quarter Net Product Sales of $136.4 Million with Approximately 24,200 TRxOpicapone New Drug Application Submission...
AVIDITY BIOSCIENCES GETS $35M IN IMMUNOLOGY R&D DEAL WITH ELI LILLY
Avidity Biosciences, a biotech developing drugs that deliver bits of RNA and DNA to cells to treat disease, has signed its first strategic...